Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
San Diego - On June 23, 2026, Atrium Therapeutics, Inc. (Nasdaq: RNA) disclosed the offering of inducement grants on June 20, 2026 under the Company's 2026 Employment Inducement Incentive Award Plan (2026 Inducement Plan) as a significant inducement to attract...
